Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 13Oropharyngeal Neoplasms 12Lung Neoplasms 9Laryngeal Neoplasms 8Carcinoma 8Mouth Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Hypopharyngeal Neoplasms 6Uterine Cervical Neoplasms 5Nasopharyngeal Carcinoma 5Mesothelioma, Malignant 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 4Triple Negative Breast Neoplasms 3Salivary Gland Neoplasms 3Ovarian Neoplasms 3Lymphoid Interstitial Pneumonia 3Gallbladder Neoplasms 3Testicular Neoplasms 2Seminoma 2Paranasal Sinus Neoplasms 2Medulloblastoma 2Ganglioneuroblastoma 2Fallopian Tube Neoplasms 2Cholangiocarcinoma 2Carcinoma, Transitional Cell 2Breast Neoplasms 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Vaginal Neoplasms 1

Interventions

Radiotherapy 1Radiation 1Platinum 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified × Platinum × 90 days × Clear all
NCT04580771 2026-04-15

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
22 enrolled
Gynecologic

Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified

Data powered by HemOnc (CC BY 4.0) Colophon âš¡